Lixte Biotechnology (LIXT) Short Interest Ratio & Short Volume $1.32 +0.01 (+0.38%) As of 05/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lixte Biotechnology Short Interest DataLixte Biotechnology (LIXT) has a short interest of 19,700 shares, representing 0.95% of the float (the number of shares available for trading by the public). This marks a -25.66% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 186,273 shares to cover all short positions.Current Short Interest19,700 sharesPrevious Short Interest26,500 sharesChange Vs. Previous Month-25.66%Dollar Volume Sold Short$24,822.00Short Interest Ratio0.3 Days to CoverLast Record DateApril 30, 2025Outstanding Shares2,684,000 sharesFloat Size2,080,000 sharesShort Percent of Float0.95%Today's Trading Volume3,459 sharesAverage Trading Volume186,273 sharesToday's Volume Vs. Average2% Short Selling Lixte Biotechnology? Sign up to receive the latest short interest report for Lixte Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLIXT Short Interest Over TimeLIXT Days to Cover Over TimeLIXT Percentage of Float Shorted Over Time Lixte Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202519,700 shares $24,822.00 -25.7%1.0%0.3 $1.26 4/15/202526,500 shares $33,628.50 -11.7%1.4%0.4 $1.27 3/31/202530,000 shares $36,300.00 -44.0%1.6%0.5 $1.21 3/15/202553,600 shares $64,856.00 +26.7%2.9%0.8 $1.21 2/28/202542,300 shares $54,990.00 -23.8%2.3%0.7 $1.30 2/15/202555,500 shares $80,475.00 -42.2%3.3%0.9 $1.45 1/31/202596,000 shares $232,320.00 -14.8%5.4%1.6 $2.42 1/15/2025112,700 shares $276,115.00 +2.9%6.3%0.2 $2.45 12/31/2024109,500 shares $222,285.00 -7.1%6.1%0.2 $2.03 12/15/2024117,900 shares $234,043.29 -13.6%6.6%0.2 $1.99 Get the Latest News and Ratings for LIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lixte Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024136,400 shares $304,172.00 -27.9%7.6%0.2 $2.23 11/15/2024189,100 shares $306,342.00 -57.8%10.5%0.3 $1.62 10/31/2024448,000 shares $945,280.00 +2,348.1%24.9%0.7 $2.11 10/15/202418,300 shares $32,940.00 -26.5%1.0%0.4 $1.80 9/30/202424,900 shares $46,563.00 -28.0%1.4%0.5 $1.87 9/15/202434,600 shares $68,854.00 +10.9%1.9%0.7 $1.99 8/31/202431,200 shares $55,536.00 +225.0%1.7%0.4 $1.78 8/15/20249,600 shares $19,488.00 +20.0%0.5%0.2 $2.03 7/31/20248,000 shares $17,280.00 -33.3%0.4%0.2 $2.16 7/15/202412,000 shares $28,920.00 -25.9%0.7%0.3 $2.41 6/30/202416,200 shares $38,394.00 -12.9%0.9%0.4 $2.37 6/15/202418,600 shares $45,570.00 +53.7%1.0%0 $2.45 5/31/202412,100 shares $28,291.01 -24.8%0.7%0 $2.34 5/15/202416,100 shares $36,869.00 -31.8%0.9%0 $2.29 4/30/202423,600 shares $68,204.00 -71.5%1.3%0 $2.89 4/15/202482,700 shares $272,910.00 +395.2%4.6%0.2 $3.30 3/31/202416,700 shares $56,446.00 -14.8%1.0%0 $3.38 3/15/202419,600 shares $45,276.00 -62.3%1.1%0.5 $2.31 2/29/202452,000 shares $135,200.00 +258.6%3.0%1.4 $2.60 2/15/202414,500 shares $39,440.00 +42.2%0.8%0.3 $2.72 1/31/202410,200 shares $21,063.00 +117.0%0.6%0.4 $2.07 1/15/20244,700 shares $9,118.00 -63.0%0.3%0.1 $1.94 12/31/202312,700 shares $29,845.00 -32.5%0.7%0.3 $2.35 12/15/202318,800 shares $39,668.00 -26.0%1.1%0.4 $2.11 11/30/202325,400 shares $59,182.00 -60.1%1.5%0.5 $2.33 11/15/202363,700 shares $184,730.00 +295.7%3.7%1.2 $2.90 10/31/202316,100 shares $38,720.50 -1.8%0.9%0.4 $2.41 10/15/202316,400 shares $39,360.00 -44.6%1.0%0.3 $2.40 9/30/202329,600 shares $72,520.00 +261.0%2.1%0.2 $2.45 9/15/20238,200 shares $17,384.00 +13.9%0.6%0.1 $2.12AI Bloodbath Coming on June 1st? (Ad)If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.Click here to see the details and learn how to prepare for the next AI revolution 8/31/20237,200 shares $18,036.00 -44.2%0.3%0.1 $2.51 8/15/202312,900 shares $32,250.00 -84.3%0.6%0.1 $2.50 7/31/202382,200 shares $289,344.00 +774.5%4.7%0.6 $3.52 7/15/20239,400 shares $51,042.00 +8.1%1.0%0.1 $5.43 6/30/20238,700 shares $50,721.00 -28.7%0.5%0.4 $5.83 6/15/202312,200 shares $57,950.00 +306.7%1.5%0.7 $4.75 5/31/20233,000 shares $20,784.00 -86.2%0.4%0.3 $6.93 5/15/202321,800 shares $14,483.92 +162.7%0.3%0.2 $0.66 4/30/20238,300 shares $4,656.30 -80.0%0.1%0 $0.56 4/15/202341,500 shares $26,153.30 -45.8%0.5%0 $0.63 3/31/202376,500 shares $63,288.45 -39.1%1.0%0.1 $0.83 3/15/2023125,700 shares $85,853.10 +31.5%1.7%0.1 $0.68 2/28/202395,600 shares $86,757.00 -38.7%1.3%0.1 $0.91 2/15/2023156,000 shares $180,960.00 +459.1%2.1%0.1 $1.16 1/31/202327,900 shares $22,041.00 -62.6%0.4%0 $0.79 1/15/202374,500 shares $42,465.00 +89.1%1.0%2 $0.57 12/30/202239,400 shares $20,054.60 -7.9%0.5%1.2 $0.51 12/15/202242,800 shares $23,171.92 -15.9%0.6%1.7 $0.54 11/30/202250,900 shares $38,938.50 +53.3%0.7%1.8 $0.77 11/15/202233,200 shares $18,283.24 +26.7%0.5%1.1 $0.55 10/31/202226,200 shares $13,105.24 +5.2%0.4%0.5 $0.50 10/15/202224,900 shares $12,980.37 -58.5%0.4%0.2 $0.52 9/30/202260,000 shares $33,612.00 +64.4%0.9%0.5 $0.56 9/15/202236,500 shares $25,761.70 -43.4%0.5%0.3 $0.71 8/31/202264,500 shares $50,310.00 -30.0%0.9%0.5 $0.78 8/15/202292,100 shares $74,582.58 +435.5%1.3%0.6 $0.81 7/31/202217,200 shares $12,934.40 -27.4%0.2%0.1 $0.75 7/15/202223,700 shares $19,434.00 +0.9%0.3%0 $0.82 6/30/202223,500 shares $17,496.93 -20.3%0.3%0 $0.74 6/15/202229,500 shares $21,537.95 -38.3%0.4%0 $0.73 5/31/202247,800 shares $35,873.90 -12.3%0.7%0 $0.75 5/15/202254,500 shares $51,824.05 -59.9%0.8%0 $0.95 4/30/2022136,000 shares $160,480.00 -92.4%2.7%0 $1.18 4/15/20221,800,000 shares $2.83 million +10,614.3%35.2%0.6 $1.57 3/31/202216,800 shares $20,664.00 +8.4%0.4%0.1 $1.23 3/15/202215,500 shares $17,050.00 -59.2%0.3%0 $1.10 2/28/202238,000 shares $53,960.00 -9.5%0.7%0 $1.42 2/15/202242,000 shares $68,460.00 -66.0%0.7%0 $1.63 1/31/2022123,600 shares $239,784.00 -62.3%2.2%0.1 $1.94 1/15/2022328,200 shares $643,272.00 +589.5%5.8%0.2 $1.96 12/31/202147,600 shares $56,644.00 +14.2%0.8%0 $1.19 12/15/202141,700 shares $57,963.00 +110.6%0.7%0.8 $1.39 11/30/202119,800 shares $32,274.00 -54.2%0.4%0.4 $1.63 11/15/202143,200 shares $78,192.00 -20.2%0.8%0.9 $1.81 10/29/202154,100 shares $101,708.00 +0.4%1.0%0.7 $1.88 10/15/202153,900 shares $100,793.00 +11.4%1.0%0.1 $1.87 9/30/202148,400 shares $100,672.00 +25.4%0.9%0.1 $2.08 9/15/202138,600 shares $84,148.00 +196.9%0.7%0.1 $2.18 8/31/202113,000 shares $31,980.00 -80.7%0.2%0 $2.46 8/13/202167,400 shares $150,976.00 +2,006.3%1.2%0.2 $2.24Warning: Prepare to Be Shocked by These Payouts (Ad)There's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don't even pay dividends. It's fast, it's legal, and most people have no clue it exists.Click here to see how much you could be collecting each month → 7/30/20213,200 shares $8,800.00 -82.4%0.1%0 $2.75 7/15/202118,200 shares $54,418.00 -37.5%0.3%0.1 $2.99 6/30/202129,100 shares $88,173.00 +193.9%0.5%0.1 $3.03 6/15/20219,900 shares $29,304.00 -66.9%0.2%0 $2.96 5/28/202129,900 shares $81,926.00 +81.2%0.5%0.1 $2.74 5/14/202116,500 shares $42,817.50 -45.7%0.3%0 $2.60 4/30/202130,400 shares $87,856.00 +98.7%0.5%0 $2.89 4/15/202115,300 shares $45,441.00 -62.7%0.3%0 $2.97 3/31/202141,000 shares $132,020.00 +151.5%1.0%0 $3.22 3/15/202116,300 shares $71,231.00 -13.8%0.4%0 $4.37 2/26/202118,900 shares $71,253.00 +575.0%0.5%0 $3.77 2/12/20212,800 shares $10,220.00 +64.7%0.1%0 $3.65 1/29/20211,700 shares $5,346.50 -15.0%0.1%0 $3.15 1/15/20212,000 shares $6,520.00 No Change0.1%0 $3.26 11/15/20208,400 shares $9,492.00 +140.0%N/A2.8 $1.13 10/30/20203,500 shares $3,920.00 +2.9%N/A3.9 $1.12 10/15/20203,400 shares $3,910.00 +17.2%N/A2.1 $1.15 9/30/20202,900 shares $3,393.00 +107.1%N/A1.4 $1.17 9/15/20201,400 shares $1,400.00 +40.0%N/A0.1 $1.00 8/31/20201,000 shares $1,180.00 -9.1%N/A0.3 $1.18 8/14/20201,100 shares $1,298.00 +37.5%N/A0.7 $1.18 7/31/2020800 shares $952.00 -84.0%N/A0.1 $1.19 7/15/20205,000 shares $4,400.00 -2.0%N/A1.4 $0.88 6/30/20205,100 shares $4,590.00 +13.3%N/A3 $0.90 6/15/20204,500 shares $4,050.00 +12.5%N/A3.2 $0.90 5/29/20204,000 shares $3,520.00 No ChangeN/A1 $0.88 LIXT Short Interest - Frequently Asked Questions What is Lixte Biotechnology's current short interest? Short interest is the volume of Lixte Biotechnology shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 19,700 shares of LIXT short. 0.95% of Lixte Biotechnology's shares are currently sold short. Learn More on Lixte Biotechnology's current short interest. What is a good short interest percentage for Lixte Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.95% of Lixte Biotechnology's floating shares are currently sold short. Is Lixte Biotechnology's short interest increasing or decreasing? Lixte Biotechnology saw a decline in short interest in April. As of April 30th, there was short interest totaling 19,700 shares, a decline of 25.7% from the previous total of 26,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lixte Biotechnology's float size? Lixte Biotechnology currently has issued a total of 2,684,000 shares. Some of Lixte Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lixte Biotechnology currently has a public float of 2,080,000 shares. How does Lixte Biotechnology's short interest compare to its competitors? 0.95% of Lixte Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lixte Biotechnology: Cocrystal Pharma, Inc. (0.01%), Cingulate Inc. (5.46%), Lipocine Inc. (1.36%), Unity Biotechnology, Inc. (5.46%), Upexi, Inc. (36.93%), Moleculin Biotech, Inc. (5.18%), NeuroSense Therapeutics Ltd. (0.99%), IN8bio, Inc. (0.59%), Flora Growth Corp. (1.50%), BioCardia, Inc. (3.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Lixte Biotechnology stock? Short selling LIXT is an investing strategy that aims to generate trading profit from Lixte Biotechnology as its price is falling. LIXT shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lixte Biotechnology? A short squeeze for Lixte Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LIXT, which in turn drives the price of the stock up even further. How often is Lixte Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LIXT, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies COCP Short Interest Data CING Short Interest Data LPCN Short Interest Data UBX Short Interest Data UPXI Short Interest Data MBRX Short Interest Data NRSN Short Interest Data INAB Short Interest Data FLGC Short Interest Data BCDA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LIXT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LIXT Stock Free LIXT Stock Alerts